References

A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis

10.1210/jc.2002-020334 · 2002 · External reference

Latest on anabolic agents for osteoporosis treatment

10.1016/j.ecl.2024.08.003 · 2024 · External reference

Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis

10.1111/j.1742-7843.2004.pto940602.x · 2004 · External reference

Anabolic and antiresorptive osteoporosis treatment: trends, costs, and sequence in a commercially insured population, 2003-2021

10.1002/jbm4.10800 · 2023 · External reference

The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years

10.1002/jbmr.1768 · 2012 · External reference

Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis

10.1016/j.bone.2006.06.007 · 2006 · External reference

Variability in the measured response of bone to teriparatide

10.1007/s00198-010-1376-1 · 2011 · External reference

Predictors of teriparatide treatment failure in patients with low bone mass

10.1016/j.bonr.2015.11.001 · 2016 · External reference

Skeletal response to treatment with teriparatide (TPD) after bisphosphonate in post-menopausal women with osteoporosis and a high prevalence of secondary risk factors in real-life setting of a metabolic bone clinic; effect of age and vitamin D status

10.1080/07435800.2018.1454461 · 2018 · External reference

Impact of the environment on the skeleton: is it modulated by genetic factors?

10.1007/s11914-013-0151-6 · 2013 · External reference

Genome-wide association study identifies genetic variants which predict the response of bone mineral density to teriparatide therapy

10.1136/ard-2022-223618 · 2023 · External reference

Quantifying and correcting for the winner’s curse in genetic association studies

10.1002/gepi.20398 · 2009 · External reference

Current challenges and new opportunities for gene-environment interaction studies of complex diseases

10.1093/aje/kwx227 · 2017 · External reference

The diversity outbred mouse population

10.1007/s00335-012-9414-2 · 2012 · External reference

The collaborative cross, a community resource for the genetic analysis of complex traits

10.1038/ng1104-1133 · 2004 · External reference

Unresolved reference

1995 · External reference

Unresolved reference

External reference

Mechanical loading enhances the anabolic effects of intermittent parathyroid hormone (1-34) on trabecular and cortical bone in mice

10.1016/j.bone.2008.04.012 · 2008 · External reference

Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation

10.1016/j.bone.2007.11.017 · 2008 · External reference

Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity

10.1016/j.bone.2006.09.010 · 2007 · External reference

Intermittent fasting alleviates obesity-associated impairments in bone fracture healing: exploring the role of gut microbiome

2025 · External reference

IRE1 signaling in osteoprogenitors augments β-catenin activity and physiologic bone accrual

10.1093/jbmr/zjag001 · 2026 · External reference

Demystifying machine learning approaches in digital bone imaging using microCT and HRpQCT

2026 · External reference

Screening gene knockout mice for variation in bone mass: analysis by μCT and Histomorphometry

10.1007/s11914-018-0421-4 · 2018 · External reference

Genetic analysis in the collaborative cross breeding population

10.1101/gr.113886.110 · 2011 · External reference

Quantitative trait locus mapping methods for diversity outbred mice

10.1534/g3.114.013748 · 2014 · External reference

Analysis of common SNPs across continents reveals major genomic differences between human populations

10.3390/genes13081472 · 2022 · External reference

Pharmacogenomic testing: clinical evidence and implementation challenges

10.3390/jpm9030040 · 2019 · External reference

Treatment failure in osteoporosis: who will experience a new fracture? Tailor a retrospective study

10.1007/s40520-025-02972-2 · 2025 · External reference

Treatment failure in osteoporosis

10.1007/s00198-012-2093-8 · 2012 · External reference

Genome-wide association of an integrated osteoporosis-related phenotype: is there evidence for pleiotropic genes?

10.1002/jbmr.563 · 2012 · External reference

Genetic determinants of bone density and fracture risk—state of the art and future directions

10.1210/jc.2009-2406 · 2010 · External reference

Teriparatide increases strength of the peripheral skeleton in premenopausal women with idiopathic osteoporosis: a pilot HR-pQCT study

10.1210/jc.2014-1041 · 2014 · External reference

Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT Study

10.1002/jbmr.2315 · 2015 · External reference

The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis

10.1359/jbmr.2003.18.1.9 · 2003 · External reference

Analysis of daily teriparatide treatment for osteoporosis in men

10.1007/s00198-014-3001-1 · 2015 · External reference

A perspective on muscle phenotyping in musculoskeletal research

10.1016/j.tem.2024.01.004 · 2024 · External reference

Sexual dimorphism in the musculoskeletal system: sex hormones and beyond

10.1210/jendso/bvae153 · 2024 · External reference

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

10.1056/nejm200105103441904 · 2001 · External reference

Site-specific differences in osteoblast phenotype, mechanical loading response and estrogen receptor-related gene expression

10.1016/j.mce.2018.06.011 · 2018 · External reference

Effects of a single injection of teriparatide on bone turnover markers in postmenopausal women

10.1007/s00198-012-2159-7 · 2013 · External reference

Osteoclast formation in bone marrow cultures from two inbred strains of mice with different bone densities

10.1359/jbmr.1999.14.1.39 · 1999 · External reference

Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis

10.1007/s00198-010-1226-1 · 2011 · External reference